Results 171 to 180 of about 578,179 (195)

The Bruton tyrosine kinase inhibitor acalabrutinib aborts ongoing acute food-induced anaphylactic reactions in humanized mice. [PDF]

J Allergy Clin Immunol
Arce B, Vilela NM, Chichester KL, Sokol KA, Alvarez-Arango S, Iacobelli L, Oliver ET, Croote D, Bochner BS, MacGlashan DW, Dispenza MC.   +10 more
europepmc   +1 more source

Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis. [PDF]

J Neuroinflammation
Xiao Z, Li Z, Zhu W, Chen G, Luo X, Mai Z, Wang M, Huang H, Li Z, Shi Y, Xie Y, Wu H, Chen X, Liang D.   +13 more
europepmc   +1 more source

Bruton's Tyrosine Kinase Inhibitors: Recent Updates. [PDF]

Int J Mol Sci
Fares A, Carracedo Uribe C, Martinez D, Rehman T, Silva Rondon C, Sandoval-Sus J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Pharmacology & Therapeutics, 1999
Pascal Furet, Peter Traxler, P Traxler
exaly  

Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases

Trends in Cell Biology, 2001
Frank-D Böhmer, A Östman
exaly  

The protein tyrosine kinase family of the human genome

Oncogene, 2000
Su-Fang Lin, D R Robinson
exaly  

Tyrosine Kinase Receptors in Oncology

International Journal of Molecular Sciences, 2020
Alfredo Carrato, Javier Torres Jiménez, Juan José Soto Castillo   +2 more
exaly  

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology, 2018
Sai-Hong Ou, Samuel J Klempner, Russell Madison   +2 more
exaly